Knapen, Daan G. http://orcid.org/0000-0002-2523-137X
Hone Lopez, Sara http://orcid.org/0000-0001-7615-3474
de Groot, Derk Jan A.
de Haan, Jacco-Juri http://orcid.org/0000-0002-1629-4715
de Vries, Elisabeth G. E. http://orcid.org/0000-0002-8949-7425
Dienstmann, Rodrigo
de Jong, Steven http://orcid.org/0000-0001-5831-6997
Bhattacharya, Arkajyoti http://orcid.org/0000-0003-1479-0739
Fehrmann, Rudolf S. N. http://orcid.org/0000-0002-7516-315X
Article History
Received: 25 April 2023
Accepted: 19 April 2024
First Online: 3 May 2024
Competing interests
: De Vries reports Institutional Financial Support for her advisory role from Crescendo Biologics, Daiichi Sankyo and NSABP, and Institutional Financial Support for clinical trials or contracted research from Amgen, AstraZeneca, Bayer, Crescendo Biologics, CytomX Therapeutics, G1 Therapeutics, Genentech, GE Healthcare, Regeneron, Roche and Servier, all outside the submitted work. De Haan reports Institutional Financial Support for clinical trials or contracted research from Astellas, Boehringer, Cogent, Incyte, Inhibrx, Zentalis, Zymeworks, all outside the submitted work. The other authors do not report any conflict of interest.